Best Doctors for Multiple Myeloma in Los Angeles
U.S. News & World Report “Best Doctors for Myeloma in Los Angeles” Article
read moreExtensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research
Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the…
read moreExtensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research TRANSCRIPT
Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the…
read moreRuxolitinib Is Under Investigation as JAK Inhibition Strategy for Multiple Myeloma
CancerNetwork® spoke with James R. Berenson, MD, founder, medical and scientific director, and president and…
read moreRuxolitinib Elicits Few Adverse Effects When Treating Multiple Myeloma
CancerNetwork® spoke with James R. Berenson, MD, president and medical director of the Berenson Cancer…
read moreRuxolitinib/Selinexor Combo Is Being Evaluated for Multiple Myeloma
Encouraging preclinical data foreground a clinical trial evaluating ruxolitinib (Jakafi) with selinexor (Xpovio) in patients…
read moreExploring the Potential Role of JAK Inhibitors in Multiple Myeloma
CancerNetwork® spoke with James R. Berenson, MD, about the potential role that JAK inhibitors may…
read moreLaunch of Myeloma BioBank
The Exciting Launch of Myeloma BioBank: James R. Berenson, MD, Multiple Myeloma, specialist announced in an interview…
read moreTargeted Oncology
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly…
read moreAmerican Society of Hematology
Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11…
read more